Day 2 at MGMA17 started very early for exhibitors when the doors to the exhibit hall opened sharply at 6:30am Pacific Time. It was clear that MGMA organizers...
Archive - October 10, 2017
Geisinger has struck a deal with Boehringer Ingelheim to develop a risk-prediction model for three of the most common adverse outcomes from type 2 diabetes...
We’re excited to share the topic and questions for this week’s #HITsm chat happening Friday, 10/13 at Noon ET (9 AM PT). This week’s chat will be hosted by...